Table 3.
Nonelderly (0-64 yr of age) lifetime total costs and OOP costs attributable to SCD and their decomposition into costs due to the intensity and mortality effects
| Sex | LE (0-64), yr (SCD vs Matched Controls) | Survival-adjusted Costs for SCD Individuals (95% CI) | Survival-adjusted Costs for Matched Controls (95% CI) | SCD-attributable Costs (95% CI) | SCD-attributable Intensity Effect (95% CI) | SCD-attributable Mortality Effect (95% CI) |
|---|---|---|---|---|---|---|
| Total Costs, $ | ||||||
| Females | 51.2 vs 62.3 | 1 812 743 (1 489 450 to 2 136 036) | 224 623 (191 989 to 257 256) | 1 588 120 (1 262 183 to 1 914 057) | 1 644 900 (1 319 718 to 1 970 082) | −56 780 (−85 270 to −28 290) |
| Males | 50.5 vs 60.3 | 1 937 966 (1 612 327 to 2 263 605) | 189 133 (154 174 to 224 093) | 1 748 832 (1 420 634 to 2 077 031) | 1 792 774 (1 465 038 to 2 120 511) | −43 942 (−75 860 to −12 023) |
| OOP Costs, $ | ||||||
| Females | 51.2 vs 62.3 | 67 003 (60 597 to 73 409) | 24 609 (21 084 to 28 134) | 42 395 (34 756 to 50 033) | 48 562 (41 264 to 55 861) | −6 168 (−9 198 to −3 138) |
| Males | 50.5 vs 60.3 | 67 897 (60 696 to 75 098) | 22 806 (18 479 to 27 132) | 45 091 (36 491 to 53 691) | 50 346 (42 005 to 58 686) | −5 254 (−9 188 to −1 320) |
LE, life expectancy.